Comparison of Treatment Outcomes among Second-Line Antiretroviral Regimens in HIV/AIDS Patient
Antiretroviral (ARV) therapy can increase life expectancy of people living with HIV/AIDS (PLWHA). If the therapy fails and causes severe toxicity to first-line ARV, the first-line ARV regimen is switched to the second line. Studies on the outcome of the second-line ARV therapy have not been widely c...
Main Authors: | Winda Dwi Puspitasari, Nanang Munif Yasin, Fita Rahmawati |
---|---|
Format: | Article |
Language: | Indonesian |
Published: |
Universitas Gadjah Mada
2018-10-01
|
Series: | Jurnal Manajemen dan Pelayanan Farmasi |
Subjects: | |
Online Access: | https://jurnal.ugm.ac.id/jmpf/article/view/36414 |
Similar Items
-
Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
by: Sonali Salvi, et al.
Published: (2022-12-01) -
Response to antiretroviral therapy undergone by HIV/AIDS patients
by: Nanang Munif Yasin, et al.
Published: (2011-07-01) -
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
by: Eva Agnes Odongpiny Laker, et al.
Published: (2019-03-01) -
Dolutegravir for second-line treatment: Programmatic implications of new evidence
by: Ying Zhao, et al.
Published: (2022-09-01) -
Incidence and Predictors of Virological Failure Among Adult HIV/AIDS Patients on Second-Line Anti-Retroviral Therapy, in Selected Public Hospital of Addis Ababa, Ethiopia: Retrospective Follow-Up Study
by: Zakaria HF, et al.
Published: (2022-07-01)